Guidance Moves at a Glacial Pace. Despite growing awareness of the deficiency, and an advocacy group made up of grieving friends and relatives who push for routine testing of all patients before they ...

Last week, ESPN anchor Jay Harris, 60, announced on Good Morning America (GMA) that he’d been diagnosed with prostate cancer.. In an essay published in ESPN Front Row, the veteran SportsCenter anchor ...

Combining standard adjuvant chemotherapy with the immune checkpoint inhibitor atezolizumab [Tecentriq] leads to a significant improvement in disease-free survival in a subset of patients with Stage ...

T he mortality rate study caught the attention of Scott Atlas, a health policy expert at the Hoover Institution, a conservative public policy think tank. Atlas had opposed lockdowns early in the ...

Use of popular weight-loss medications, such as semaglutide and tirzepatide, was associated with a moderately lower risk for obesity-related cancers, especially colon and rectal cancer, and reduced ...

People with advanced small-cell lung cancer (SCLC) who received lurbinectedin (Zepzelca) chemotherapy plus atezolizumab (Tecentriq) immunotherapy as a maintenance regimen after initial treatment had ...

Features The GOP’s Trying Again To Cut Medicaid. It’s Only Gotten Harder Since 2017.

Nearly three quarters of non-small-cell lung cancer (NSCLC) patients with HER2 mutations experienced tumor regression when treated with zongertinib, a novel targeted therapy, according to results from ...

Cancer Health Stories Deciding Not to Treat My Cancer. Active surveillance spares men with low-risk prostate cancer, like me, from aggressive treatment and its side effects.

There were two approved approaches. One is a pill that you take indefinitely [a BTK inhibitor, which is a type of targeted therapy]. The other is a more intensive combination of IV treatments every ...

A call by the U.S. surgeon general for a new warning about alcohol’s links to cancer is the latest effort to raise awareness about a health issue that many Americans aren’t aware of.

More than 11,000 researchers, clinicians, patient advocates and drugmakers gathered earlier this month to share the latest treatments, tricks and tools to take down breast cancer, which continues to ...